Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Code:
NCT01668186
Conditions
Peroxisome Biogenesis Disorder
Zellweger Spectrum Disorder
RCDP - Rhizomelic Chondrodysplasia Punctata
D-Bifunctional Protein Deficiency
Alpha-Methylacyl-CoA Racemase Deficiency
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Peroxisome Biogenesis Disorder
Zellweger Spectrum Disorder
RCDP - Rhizomelic Chondrodysplasia Punctata
D-Bifunctional Protein Deficiency
Alpha-Methylacyl-CoA Racemase Deficiency
Study ID
NCT01668186
Start date
Jan, 2012
Status verified date
Dec, 2025
Completion date
Jan, 2031
Anticipated
Primary completion date
Jan, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
244 participants
Anticipated
Arms
Patients diagnosed with a peroxisomal disorder
Primary outcome measure
Central contacts
Locations
Research Institute of the McGill University Health Center
Recruiting
Montreal, Quebec, Canada, H4A 3J1
Principal Investigator:
Nancy E Braverman, MD, MS
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Last update posted
Dec 10, 2025
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre on 2025-12-10.